As reported by Lytle, Allen’s mother has also battled against Alzheimer’s.

The data came from the ongoing Adult-Children Study at the university’s Charles F. and Joanne Knight Alzheimer’s Disease Research Center. Yet 71 percent of African Americans had Alzheimer’s disease mixed with evidence of other brain-damaging pathologies, such as Lewy bodies or dead tissue caused by inadequate circulation. Scientists have been following participants with and without a family history of the disease, with the aim of identifying Alzheimer’s biomarkers most closely associated with the development of full-blown disease years later. They noted whether people had just one pathology or more than one.

Dr Doug Brown, director of research at Alzheimer’s Society, said: “There are 850,000 people with Dementia in the United Kingdom and the majority have Alzheimer’s disease”.

“Studying how Alzheimer’s disease looks in the brain in individuals of different races may help us to further understand the disease and pinpoint strategies for prevention and treatment”, Dr. Barnes said in the press release. And, black people seem more likely to suffer different types of brain changes that also contribute to dementia, a new study reports. This team will use novel methods combined with an established imaging approach to measure the activity of the glymphatic system for the first time in human patients. Named after their discoverer in 1912, Lewy bodies disrupt the brain’s normal functioning, sometimes producing hallucinations, delirium and other dramatic changes in a person’s behavior, including body rigidity and trembling that resembles Parkinson’s disease. Focused both on discovery and on mentoring future generations of researchers, Salk scientists make groundbreaking contributions to our understanding of cancer, aging, Alzheimer’s, diabetes and infectious diseases by studying neuroscience, genetics, cell and plant biology and related disciplines.

According to these findings, by keenly observing the changes to biomarkers during midlife it might be possible to assess if a specific patient of Alzheimer’s could be afflicted by dementia later in his/her life. Since inception, the Foundation has awarded $575 million to more than 1,500 nonprofit groups to support and advance their critical charitable endeavors in the Pacific Northwest and beyond.

That’s good news, to be sure, but cross-disciplinary teams such as the ones Allen is supporting might have trouble accessing that money, Lytle says. “We’re in the process of putting together a 10-year plan for the topics we want to go after, and given that interest, I can see a role for neurodegenerative disease and Alzheimer’s specifically”.